- Home
- MNPR vs LDI Comparison
MNPR vs LDI Comparison
Compare MNPR & LDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- LDI
- Stock Information
- Founded
- MNPR 2014
- LDI 2010
- Country
- MNPR United States
- LDI United States
- Employees
- MNPR N/A
- LDI N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- LDI Finance: Consumer Services
- Sector
- MNPR Health Care
- LDI Finance
- Exchange
- MNPR Nasdaq
- LDI Nasdaq
- Market Cap
- MNPR 248.8M
- LDI 221.2M
- IPO Year
- MNPR 2019
- LDI 2021
- Fundamental
- Price
- MNPR $44.21
- LDI $2.89
- Analyst Decision
- MNPR Strong Buy
- LDI Sell
- Analyst Count
- MNPR 10
- LDI 3
- Target Price
- MNPR $66.56
- LDI $2.30
- AVG Volume (30 Days)
- MNPR 38.8K
- LDI 4.0M
- Earning Date
- MNPR 11-07-2025
- LDI 11-04-2025
- Dividend Yield
- MNPR N/A
- LDI N/A
- EPS Growth
- MNPR N/A
- LDI N/A
- EPS
- MNPR N/A
- LDI N/A
- Revenue
- MNPR N/A
- LDI $1,124,074,000.00
- Revenue This Year
- MNPR N/A
- LDI $21.95
- Revenue Next Year
- MNPR N/A
- LDI $15.72
- P/E Ratio
- MNPR N/A
- LDI N/A
- Revenue Growth
- MNPR N/A
- LDI 27.06
- 52 Week Low
- MNPR $2.29
- LDI $1.01
- 52 Week High
- MNPR $54.30
- LDI $3.23
- Technical
- Relative Strength Index (RSI)
- MNPR 65.29
- LDI 77.55
- Support Level
- MNPR $32.77
- LDI $1.81
- Resistance Level
- MNPR $36.49
- LDI $2.16
- Average True Range (ATR)
- MNPR 2.93
- LDI 0.19
- MACD
- MNPR 1.14
- LDI 0.06
- Stochastic Oscillator
- MNPR 99.97
- LDI 92.31
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About LDI loanDepot Inc.
loanDepot Inc provides nonbank consumer lending solutions for individuals in the United States. It offers personal, residential home, home refinancing, mortgage and home equity loans. It also provides online mortgage loans for refinancing and home purchases. It serves customers through distribution channels, including consumer direct centres, retail branches, wholesale centres, and consumer finance and servicing centres in the United States. It competes with commercial banks and financial institutions.